Exploring the cytotoxic potential of neocryptolepine derivatives against cancer

Announcing a new publication for Acta Materia Medica journal. Cancer has been a severe public health and social problem, a leading disease that has diminished the quality of life, and a barrier to improving life expectancy.

Abridge & NVIDIA Partner to Supercharge AI-powered Clinical Documentation

What You Should Know: – Abridge, a leader in generative AI for healthcare documentation forms a strategic collaboration with NVIDIA to leverage NVIDIA’s cutting-edge technology

March 20, 2024

Risk Adjusted Net Present Value: What is the current valuation of Aligos Therapeutics’s ALG-009

The revenue for ALG-009 is expected to reach an annual total of $6 mn by 2037 globally based off GlobalData’s Expiry Model. The drug’s revenue

November 4, 2023

Sanofi’s Mourenx production site leaked a potentially cancerous neurotoxin for the second time

Sanofi’s chemical production facility in Mourenx, France, is under scrutiny again after leaking an excess of the neurotoxin bromopropane, having been temporarily shut down five

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.